Hepatic encephalopathy in the age of TIPS
Andres T. Blei – 1 July 1994
The molecular genetics of autoimmune liver disease
Peter Donaldson, Derek Doherty, James Underhill, Roger Williams – 1 July 1994 – The dual observations that human leukocyte antigens have an antigen‐binding groove and that the polymorphism we study as human leukocyte antigen types is largely related to amino acid substitutions in and around that groove have provided a new focus for immunogenetic studies.
Urokinase and type I plasminogen activator inhibitor production by normal human hepatocytes: Modulation by inflammatory agents
Nathalie Busso, Edwige Nicodeme, Christophe Chesne, André Guillouzo, Dominique Belin, François Hyafil – 1 July 1994 – We examined the effects of inflammatory cytokines (interleukin‐1β, tumor necrosis factor‐α and transforming growth factor‐β) on the plasminogen activator system (urokinase, tissue‐type plasminogen activator, type 1 plasminogen activator inhibitor) in primary cultures of human hepatocytes.
Predicting recidivism after orthotopic liver transplantation for alcoholic liver disease
Robert W. Osorio, Nancy L. Ascher, Mark Avery, Peter Bacchetti, John P. Roberts, John R. Lake – 1 July 1994 – With appropriate selection criteria, patients with end‐stage alcoholic liver disease who undergo orthotopic liver transplantation have similar graft and patient survivals as patients undergoing transplantation for other causes. However, because of the possibility of recidivism after orthotopic liver transplantation there is still reluctance to transplant alcoholic patients.
Diagnostic and clinical implications of the different genotypes of hepatitis C virus
- Read more about Diagnostic and clinical implications of the different genotypes of hepatitis C virus
Jens Bukh, Roger H. Miller – 1 July 1994 – Hepatitis C virus (HCV) samples in 155 sera, from patients with chronic non‐A, non‐B liver disease and blood donors, were grouped into four genotypes (I, II, III, and IV) by amplification of core‐gene sequences by polymerase chain reaction with type‐specific primers. HCV genotypes were compared with various HCV‐associated antibodies detectable by the first‐generation ELISA (ELISA‐1) with C100‐3 protein and a second‐generation immunoblot assay with four recombinant HCV proteins.
Collagen‐acetaldehyde adducts in alcoholic and nonalcoholic liver diseases
Gianluca Svegliati‐Baroni, Enrique Baraona, Alan S. Rosman, Charles S. Lieber – 1 July 1994 – Alcoholic and, to a lesser extent, nonalcoholic patients with liver disease have serum antibodies to acetaldehyde‐protein adducts produced in vitro. These antibodies presumably reflect the presence of adducts in the liver, but the protein that triggers this immune response has not been identified.
Serum 7α–hydroxycholesterol reflects hepatic bile acid synthesis in patients with obstructive jaundice after external biliary drainage
Shuichiro Okamoto, Kazuhisa Fukushima, Hidetaka Higashijima, Ichiro Makino, Masanori Kishinaka, Hitoshi Oda, Hiroyuki Yamashita, Hitoshi Ichimiya, Kazuo Chijiiwa, Syoji Kuroki – 1 July 1994 – To examine the hypothesis that serum levels of 7α‐hydroxycholesterol reflect bile acid synthesis in the liver, we analyzed serum 7α‐hydroxycholesterol and bile acid output in 13 patients with obstructive jaundice after relief of biliary obstruction.
Psoriatic lesions in patients with chronic liver disease are distinct from psoriasis vulgaris lesions, as judged on basis of integrin adhesion receptors
Gianluigi Giannelli, Paola Savoia, Oronzo Schiraldi, Mario Lospalluti, Michele De Luca, Pier Carlo Marchisio, Vito Quaranta – 1 July 1994 – Psoriatic lesions are relatively frequent in patients with chronic liver disease. Furthermore, therapy with interferons tends to exacerbate the symptoms. The pathogenesis of psoriatic lesions is unclear. An important question is whether such lesions may be linked to the underlying chronic liver disease in these patients, or whether they are incidental manifestations of psoriasis vulgaris.